Varsetatug (CX-2051 antibody) is a humanized IgG1kappa monoclonal antibody inhibitor targeting EpCAM/TROP1/CD326. Varsetatug serves as the antibody component of the ADC compound CX-2051. It can be used in research on cancers including breast cancer, prostate cancer and ovarian cancer[1][2].
Molekulargewicht:
(155.116 kDa)
Reinheit:
97
CAS Nummer:
[3036004-28-8]
Target-Kategorie:
ADC Antibody,Transmembrane Glycoprotein
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten